Pnc Financial Services Group, Inc. Mustang Bio, Inc. Transaction History

Pnc Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.73 - $1.81 $2,920 - $7,240	-4,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.66 - $2.64 $6,640 - $10,560	4,000 New	4,000 $6,000
Q4 2018 Feb 08, 2019	SELL	$2.3 - $5.78 $248 - $624	-108 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$5.71 - $7.58 $616 - $818	108 New	108 $0

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.